Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
azacitidine
beta-thalassemia
biogen
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clinical trials
clostridium difficile
community-acquired bacterial pneumonia
dacogen
dana hilt
daprodustat
david chacko
david marek
What
biotech
2
×
drugs
2
×
aims
approach
august
based
bio
busy
called
days
debuts
decisions
developing
devices
epigenetic
epigenetics
fda
field
flagship’s
legacy
medicines
morning
new
news
nods
omega
opioid
past
regulatory
research
roundup
sarepta’s
seven
shkreli’s
slow
startup
step
stumble
suits
tends
Language
unset
Current search:
xconomy.com
×
drugs
×
biotech
×
" boston blog main "
×
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
